Correction of a Traffic-Defective Missense ABCB11 Variant Responsible for Progressive Familial Intrahepatic Cholestasis Type 2
International Journal of Molecular Sciences · 29.05.2025 · 26 (11) · 5232
DOI: 10.3390/ijms26115232 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.05.2025. Verfasst von Martine Lapalus und 12 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Inserm, Physiopathogénèse et Traitement des Maladies du Foie, FHU Hepatinov, 91400 Orsay, France. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 11, Cholestasis, Intrahepatic, Mutation, Missense. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation Français, Association pour la Recherche en Hépatologie Pédiatrique, CHU Bicêtre, France, Association Maladies du Foie depuis l'Enfance, AMFE, Malakoff, France.
Abstract (Originalsprache)
Progressive familial intrahepatic cholestasis type 2 (PFIC2) is a severe hepatocellular cholestasis due to biallelic variations in the ABCB11 (ATP-binding cassette B11) gene encoding the canalicular bile salt export pump (BSEP). Some missense variants identified in patients with PFIC2 do not traffic properly to the canalicular membrane. However, 4-phenybutyrate (4-PB) has been shown in vitro to partially correct the mis-trafficking of selected variants, resulting in an improvement of the medical conditions of corresponding PFIC2 patients. Herein, we report the ability of 4-PB analogous or homologous drugs and of non-4-PB related chemical correctors to rescue the canalicular expression and the activity of the folding-defective Abcb11R1128C variant. New compounds, either identified by screening a chemical library or designed by structural homology with 4-PB (or its metabolites) and synthesized, were evaluated in vitro for their ability to (i) correct the canalicular localization of Abcb11R1128C after transfection in hepatocellular polarized cell lines; (ii) restore the 3H-taurocholate transport of the Abcb11R1128C protein in Madin–Darby canine kidney (MDCK) cells stably co-expressing Abcb11 and the sodium taurocholate co-transporting polypeptide (Ntcp/Slc10A1). Glycerol phenylbutyrate (GPB), phenylacetate (PA, the active metabolite of 4-PB), 3-hydroxy-2-methyl-4-phenylbutyrate (HMPB, a 4-PB metabolite analog chemically synthesized in our laboratory) and 4-oxo-1,2,3,4-tetrahydro-naphthalene-carboxylate (OTNC, from the chemical library screening) significantly increased the proportion of canalicular Abcb11R1128C protein. GPB, PA, ursodeoxycholic acid (UDCA), alone or in combination with 4-PB, suberoylanilide hydroxamic acid (SAHA), C18, VX-445, and/or VX-661, significantly corrected both the traffic and the activity of Abcb11R1128C. Such correctors could represent new pharmacological insights for improving the condition of patients with ABCB11 deficiency due to missense variations affecting the transporter’s traffic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris-Saclay, Inserm, Physiopathogénèse et Traitement des Maladies du Foie, FHU Hepatinov, 91400 Orsay, France.
- Université Paris-Saclay, CNRS, BioCIS, 91400 Orsay, France.
- Sorbonne Université, Muséum National d'Histoire Naturelle, CNRS, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie (IMPMC), 75005 Paris, France.
- Assistance Publique-Hôpitaux de Paris, Pediatric Hepatology and Pediatric Liver Transplant Department, Reference Center for Rare Pediatric Liver Diseases, FILFOIE, ERN Rare-Liver, Faculté de Médecine Paris-Saclay, CHU B…
ORCID-Profile: Martine Lapalus, Elodie Mareux, Emmanuelle Drège, Yosra Riahi, Manon Banet, Thomas Falguières, Isabelle Callebaut, Bruno Figadère, Emmanuel Gonzales, Emmanuel Jacquemin
Förderung
- Ministère de l'Enseignement Supérieur, de la Recherche et de l'Innovation Français
- Association pour la Recherche en Hépatologie Pédiatrique, CHU Bicêtre, France
- Association Maladies du Foie depuis l'Enfance, AMFE, Malakoff, France
- Filière de santé des maladies rares du foie (FILFOIE), Paris, France
- Agence Nationale de la Recherche
- Ipsen (France)
- Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation
- Association pour la Recherche en Hépatologie Pédiatrique
Zitieren
APA
Lapalus, M., Mareux, E., Amzal, R., Drège, E., Riahi, Y., Petit, S., Banet, M., Falguières, T., Callebaut, I., Figadère, B., Joseph, D., Gonzales, E., & Jacquemin, E. (2025). Correction of a Traffic-Defective Missense ABCB11 Variant Responsible for Progressive Familial Intrahepatic Cholestasis Type 2. International Journal of Molecular Sciences, 26(11), 5232. https://doi.org/10.3390/ijms26115232
Vancouver
Lapalus M, Mareux E, Amzal R, Drège E, Riahi Y, Petit S, et al. Correction of a Traffic-Defective Missense ABCB11 Variant Responsible for Progressive Familial Intrahepatic Cholestasis Type 2. International Journal of Molecular Sciences. 2025;26(11):5232. doi:10.3390/ijms26115232
BibTeX
@article{Lapalus2025,
author = {Lapalus, Martine and Mareux, Elodie and Amzal, Rachida and Drège, Emmanuelle and Riahi, Yosra and Petit, Sylvain and Banet, Manon and Falguières, Thomas and Callebaut, Isabelle and Figadère, Bruno and Joseph, Delphine and Gonzales, Emmanuel and Jacquemin, Emmanuel},
title = {Correction of a Traffic-Defective Missense ABCB11 Variant Responsible for Progressive Familial Intrahepatic Cholestasis Type 2},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {11},
pages = {5232},
doi = {10.3390/ijms26115232}
}
EUVIMED